v3.25.4
Consolidated Statements of Comprehensive Income - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Statement of Comprehensive Income [Abstract]      
Net earnings $ 4,233 $ 4,286 $ 4,873
Foreign currency translation adjustments, net of tax expense (benefit) of $63 in 2025, $(39) in 2024 and $15 in 2023 1,481 (1,008) 407
Net investment hedging activities, net of tax expense (benefit) of $(266) in 2025, $133 in 2024 and $(109) in 2023 (971) 484 (399)
Pension and post-employment benefits, net of tax expense (benefit) of $98 in 2025, $206 in 2024 and $(6) in 2023 421 824 (30)
Cash flow hedging activities, net of tax expense (benefit) of $(18) in 2025, $16 in 2024 and $(19) in 2023 (150) 80 (84)
Other comprehensive income (loss) 781 380 (106)
Comprehensive income 5,014 4,666 4,767
Comprehensive income attributable to noncontrolling interest 7 8 10
Comprehensive income attributable to AbbVie Inc. $ 5,007 $ 4,658 $ 4,757